Delivery Order SPE2DB25D3404-SPE2DB26FULYU
Award Date 11/5/25
Potential Completion Date 11/28/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,617.32 delivery order to AmerisourceBergen Drug Corp for PROQUAD vials under a firm fixed-price contract type. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025. This is an unset-aside, competitively awarded delivery order performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella,...
- The Defense Logistics Agency awarded a delivery order valued at $9,274.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed competitively. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the...
- The Defense Logistics Agency awarded a delivery order valued at $3,308.68 to AmerisourceBergen Drug Corp on June 4, 2025, for PROQUAD vials with an ultimate completion date of June 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine product, and this order represents a routine pharmaceutical supply transaction within the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of July 22, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used to prevent measles, mumps, rubella, and varicella, representing part of the...
- The Defense Logistics Agency awarded a $2,740.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of August 26, 2025. The contract, which carries no set-aside designation, was competitively awarded and is being performed at the contractor's Conshohocken, Pennsylvania location. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,140.38 to AmerisourceBergen Drug Corp for ProQuad vials on August 11, 2025, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order supports federal medical procurement needs and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,696.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a $5,372.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of October 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. PROQUAD is a combination...
- The Defense Logistics Agency (DLA) awarded a $24,038.40 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for ProQuad vials with a completion date of December 1, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,115.45 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The prime vendor contract serves as a comprehensive global...